Therefore, it becomes reasonable to conclude that the activation of SIRT6 in Ang-II induced hypertrophy may have been related to Nmnat2 expression and SIRT6, which, in this case, acts as a negative regulator in the case of cardiac hypertrophy. The gene discussed is NMNAT2; the disease is cardiac hypertrophy.